Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
September 20, 2024 09:00 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from Nasdaq...
NASDAQ Grants Eightco’s Request for Continued Listing on The Nasdaq Capital Market
July 01, 2024 08:30 ET
|
Eightco Holdings Inc.
Continued listing is subject to meeting certain conditions by August 23, 2024 including maintaining a minimum bid price of $1.00 or more for a minimum of ten consecutive trading sessions ...